1Suppliers
5Customers
1Debt Items
14Related Chains

Simulations Plus, Inc. Suppliers

TickerNameConfidenceEvidence
SDGR Schrödinger, Inc. 85% Reciprocal relationship from SDGR graph: Reciprocal relationship from SLP graph: Reciprocal relationship from SDGR graph: Reciprocal relationship from SLP graph: Reciprocal relationship from SDGR gra…

Simulations Plus, Inc. Customers

TickerNameConfidenceEvidence
THREE-LARGEST-CUSTOMERS THREE-LARGEST-CUSTOMERS 92% Our three largest customers in terms of revenue accounted for 9 %, 5 %, and 3 % of total revenues, respectively, for the six months ended February 28, 2026.
ADMET-PREDICTOR ADMET-PREDICTOR 90% ADMET Predictor® • 13 new clients • 10 upsells to existing clients
GASTROPLUS GASTROPLUS 90% GastroPlus® • 16 new clients • 6 upsells to existing clients
MONOLIXSUITE MONOLIXSUITE 90% MonolixSuite • 11 new clients • 7 upsells to existing clients
SDGR Schrödinger, Inc. 72% Reciprocal relationship from SDGR graph: g technology. Our ability to remain competitive will largely depend on our ability to continue to improve our computational platform and demonstrate success i…

Simulations Plus, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SLP-DEBT Debt stack $508,000 90% Market cache reports total debt of $508,000.

Simulations Plus, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Simulations Plus, Inc..

Simulations Plus, Inc. Ownership

HolderNameConfidenceEvidence
SLP-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 160 tracked holders.

Simulations Plus, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NVSEF Novartis AG 100.00 2
NVO Novo Nordisk A/S 100.00 2
CDNS Cadence Design Systems, Inc. 100.00 2
LLY Eli Lilly and Company 100.00 2
RXRX Recursion Pharmaceuticals, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
APRE Aprea Therapeutics, Inc. 100.00 2
MRK Merck & Co., Inc. 100.00 2
SDGR Schrödinger, Inc. 42.84 1 ['customer', 'supplier']
GPCR Structure Therapeutics Inc. 17.45 2
SNYNF Sanofi 17.45 2